Verbena Attenuates Adriamycin-Induced Renal Tubular Injury via Inhibition of ROS-ERK1/2-NLRP3 Signal Pathway

MLA

Yicen Zhou, et al. “Verbena Attenuates Adriamycin-Induced Renal Tubular Injury via Inhibition of ROS-ERK1/2-NLRP3 Signal Pathway.” Evidence-Based Complementary and Alternative Medicine, vol. 2022, Sept. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1155/2022/7760945.

APA

Yicen Zhou, Qijing Wu, Zhenfang Du, Min Huang, Kun Gao, Xiaowei Ma, Hui Zhang, Sheng Qiang, & Wei Sun. (2022). Verbena Attenuates Adriamycin-Induced Renal Tubular Injury via Inhibition of ROS-ERK1/2-NLRP3 Signal Pathway. Evidence-Based Complementary and Alternative Medicine, 2022, 1–11. https://doi.org/10.1155/2022/7760945

Chicago

Yicen Zhou, Qijing Wu, Zhenfang Du, Min Huang, Kun Gao, Xiaowei Ma, Hui Zhang, Sheng Qiang, and Wei Sun. 2022. “Verbena Attenuates Adriamycin-Induced Renal Tubular Injury via Inhibition of ROS-ERK1/2-NLRP3 Signal Pathway.” Evidence-Based Complementary and Alternative Medicine 2022 (September): 1–11. doi:10.1155/2022/7760945.